Navigation Links
FDA Grants Orphan Drug Designation for Nektar's Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
Date:4/21/2011

SAN FRANCISCO, April 21, 2011 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the company's oncology drug candidate, NKTR-102, has been granted orphan drug status for the treatment of women with ovarian cancer by the U.S. Food and Drug Administration (FDA).

"This designation is an important step in the overall development program for NKTR-102 and underscores our commitment to treating women with ovarian cancer," said Dr. Lorianne Masuoka, Senior Vice President and Chief Medical Officer of Nektar Therapeutics.

Nektar has a Phase 2 study ongoing for NKTR-102 that is enrolling approximately 125 patients with platinum-resistant ovarian cancer whose disease has progressed following treatment with pegylated liposomal doxorubicin (PLD) therapy.  In addition, Phase 3 planning is also underway for NKTR-102 in ovarian cancer.  For more information about clinical trials for NKTR-102, please visit the Nektar Therapeutics website at www.nektar.com or www.clinicaltrials.gov.

NKTR-102 is an investigational agent and is not approved by the FDA, the European Medicines Agency (EMA) or other Health Authorities.

About Orphan Drug Designation in the U.S.In the United States, the Orphan Drugs Act (ODA) provides for the orphan drug designation which aims to encourage the development of drugs involved in the diagnosis, prevention or treatment of a medical condition affecting fewer than 200,000 people in the country. The designation grants U.S. market exclusivity to a drug for a particular indication for a seven-year period if the sponsor complies with certain FDA specifications. Additional incentives for the sponsor include tax credits related to clinical trial expenses and a possible exemption from the FDA-user fee. The designation does not shorten the duratio
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration
2. FDA Grants 510(k) Clearance to Life Technologies Stem Cell Growth Medium
3. Court Grants Preliminary Approval to Class Action Settlement that Provides Benefits Of Approximately $20 Million to Healthcare Providers that Purchased a SS1 Before January 1, 2009
4. Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
5. FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder
6. Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe
7. FTC Grants Early Termination of Waiting Period Under Hart-Scott-Rodino Act
8. FDA Grants Orphan Drug Designation to Bayers Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors
9. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
10. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
11. HA&W Obtains Approximately $2 M in Credits and Cash Grants for Clients Through the Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... Israel , July 21, 2014 Galmed ... clinical-stage biopharmaceutical company focused on the development and commercialization ... liver diseases and cholesterol gallstones, announced today that it ... July 25, 2014 to discuss results for the period ... on current developments with respect to its clinical program ...
(Date:7/21/2014)... 2014   Aventura , the leader for ... today that MemorialCare Health System , a ... solution at the Orange Coast Memorial Medical ... Orange Coast Memorial is a 218-bed general ... patients annually. The Aventura Roaming Aware Desktop (RAD) ...
(Date:7/21/2014)... 21, 2014  A new Journal of the ... and scheduled to appear in the August 13 print ... new Hepatitis C Virus (HCV) treatments such as Sovaldi ... CVS Caremark (NYSE: CVS ) Chief Medical ... William Shrank , M.D., suggest that the discussion ...
Breaking Medicine Technology:Galmed Pharmaceuticals Second Quarter 2014 Conference Call and Webcast Scheduled for Friday, July 25, 2014 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 3MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 4CVS Caremark JAMA Commentary: New Hepatitis C Treatments Highlight Need to Control Costs of High-Priced Specialty Medications 2CVS Caremark JAMA Commentary: New Hepatitis C Treatments Highlight Need to Control Costs of High-Priced Specialty Medications 3
(Date:7/22/2014)... With over 170,000 students now playing high school ... during practice and competition, according to a new study ... Center for Injury Research and Policy at Nationwide Children,s ... today by The American Journal of Sports Medicine ... injuries over the four academic years from 2008 through ...
(Date:7/22/2014)... 2014 Garland’s new Energizer BK ... be used as a flood coat over new and ... a premium restoration material. It provides natural resistance to ... and reducing life-cycle costs. Energizer BK is specially formulated ... water resistance in addition to superior strength and flexibility. ...
(Date:7/22/2014)... CareTouch Communications, Inc. has formed a new ... . CareTouch employees will select causes they are passionate ... line with their mission to help people in and ... cause is Hike for Hospice, to benefit the Butterfly ... 14, the CareTouch in the Community team will climb ...
(Date:7/22/2014)... 2014 Most people encounter the same two problems ... and the second is a fast metabolism. These are hard problems ... provides ways to help fight these problems and to finally gain ... people out there who just can’t seem to eat more than ... are full. The cause of this problem can vary. For some ...
(Date:7/22/2014)... 22, 2014 A new and technologically ... laxity with results that are surprising even the most ... the skin with radio frequency, ThermiTight has been dubbed ... under the skin to “inject” heat to the tissues ... this single treatment solution for skin laxity produces results ...
Breaking Medicine News(10 mins):Health News:High school lacrosse players at risk of concussions other injuries 2Health News:High school lacrosse players at risk of concussions other injuries 3Health News:Energizer® BK Waterproof Coating from Garland Canada Reduces Life-Cycle Costs 2Health News:CareTouch is a Peak Sponsor for the 9th Annual Hike for Hospice in Morrison, Colorado 2Health News:CB-1 Weight Gainer Provides Two Tips to Help Customers Gain Weight 2Health News:New Minimally Invasive Procedure, ThermiTight, “Injects” Radio Frequency to Treat Skin Laxity 2
... report by the public services watchdog, the hospitals in Scotland ... with potentially// fatal condition known as ‘Deep vein thrombosis’ (DVT), ... the leg. ,An enquiry that was conducted in ... DVT, found that the failure to diagnose the condition had ...
... other form of treatment. But to a benefit of all GPs ... ,A resident artist much like resident doctors has been ... Susan Grant, a graduate of the Edinburgh School of Art. ... Council. ,It is one of 27 projects across Scotland ...
... It’s all wired at birth. Even the sex drive, researchers say. ... work to cure 'sex addicts'// , for the answer lies in ... more driven than others in seeking carnal pleasures. ,We ... University of the Negev in Israel. ,The scientists say ...
... bird flu in humans, a senior doctor in Moscow has ... but avian influenza in birds has claimed around 1.1 million ... have started tests on 120 volunteers," said Vitaly Zverev, the ... are mainly medical staff, doctors and donors. They are all ...
... plan to expand joint research into oral and throat ... ,The cooperation between Singapore's National Cancer Centre (NCC) and ... programme credited with cutting the death rate from mouth ... percent. ,The new joint effort, signed Monday, ...
... was found that people who were in their sixties have ... in an increase in the rates of cosmetic surgery. The ... among the procedures used in these surgeries. Statistics show ... of men and women in their sixties having cosmetic surgery ...
Cached Medicine News:Health News:Hospitals In Scotland Not Diagnosing DVT Properly 2
An intermediate set providing a greater range of telescopes than the starter set....
Significantly more compact and tidier in overall looks yet retain many of the excellent features of the more comprehensive Haag type systems., ,Filters include Cobalt blue; green (red free); neut...
... up to 20 tilting ... in the vertical, horizontal ... the option to offset ... transillumination., ,Filters include Cobalt ...
With a high lens and filter range this ophthalmoscope is ideal for the Primary Care Specialist...
Medicine Products: